231 related articles for article (PubMed ID: 8089316)
1. Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro.
Usenius JP; Kauppinen RA; Vainio PA; Hernesniemi JA; Vapalahti MP; Paljärvi LA; Soimakallio S
J Comput Assist Tomogr; 1994; 18(5):705-13. PubMed ID: 8089316
[TBL] [Abstract][Full Text] [Related]
2. In vivo proton magnetic resonance spectroscopy of brain tumors.
Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.
Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D
Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847
[TBL] [Abstract][Full Text] [Related]
4. In vivo 1H-spectroscopy of human intracranial tumors at 1.5 tesla. Preliminary experience at a clinical installation.
Henriksen O; Wieslander S; Gjerris F; Jensen KM
Acta Radiol; 1991 Mar; 32(2):95-9. PubMed ID: 2031809
[TBL] [Abstract][Full Text] [Related]
5. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
Kinoshita Y; Yokota A
NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
[TBL] [Abstract][Full Text] [Related]
6. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Sep; 22(7):1017-24. PubMed ID: 15288143
[TBL] [Abstract][Full Text] [Related]
7. Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: metabolite peak-area ratios, relaxation times, and absolute concentrations.
Cheong JL; Cady EB; Penrice J; Wyatt JS; Cox IJ; Robertson NJ
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1546-54. PubMed ID: 16908578
[TBL] [Abstract][Full Text] [Related]
8. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro.
Usenius JP; Vainio P; Hernesniemi J; Kauppinen RA
J Neurochem; 1994 Oct; 63(4):1538-43. PubMed ID: 7931308
[TBL] [Abstract][Full Text] [Related]
9. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
Luan W; Zhang J
Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
[TBL] [Abstract][Full Text] [Related]
10. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
[TBL] [Abstract][Full Text] [Related]
11. Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.
Simmons A; Smail M; Moore E; Williams SC
Magn Reson Imaging; 1998 Apr; 16(3):319-30. PubMed ID: 9621973
[TBL] [Abstract][Full Text] [Related]
12. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
[TBL] [Abstract][Full Text] [Related]
13. In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry.
Chen J; Huang SL; Li T; Chen XL
Neuroradiology; 2006 May; 48(5):312-8. PubMed ID: 16552583
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
15. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
16. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy.
Estève F; Rubin C; Grand S; Kolodié H; Le Bas JF
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):279-86. PubMed ID: 9457810
[TBL] [Abstract][Full Text] [Related]
17. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
18. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
20. In vivo 1H MRS and in vitro multinuclear MR study of human brain tumors.
Tugnoli V; Tosi MR; Barbarella G; Bertoluzza A; Ricci R; Trevisan C
Anticancer Res; 1996; 16(5A):2891-9. PubMed ID: 8917404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
